NCT07071532: A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder

Sponsor: AbbVie. Phase: PHASE1. Conditions: Bipolar Disorder